Bioprojet Pharma Sas
General
Total Cases5
Active Cases3
Patents--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 02/19/25 | REDACTED VERSION of [191] Letter, by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Attachments: # [1] Text of Proposed Order, # [2] Ex. A, # [3] Ex. B, # [4] Ex. C, # [5] Ex. D, # [6] Ex. E, # [7] Ex. F, # [8] Ex. G, # [9] Ex. H, # [10] Ex. I)(Tigan, Jeremy) (Entered: 02/19/2025) | |
| 02/19/25 | REDACTED VERSION of [190] Letter, by Bioprojet Pharma SAS, Bioprojet Societe Civile de Recherche, Harmony Biosciences, LLC. (Attachments: # [1] Text of Proposed Order, # [2] Ex. A, # [3] Ex. B, # [4] Ex. C, # [5] Ex. D, # [6] Ex. E, # [7] Ex. F, # [8] Ex. G, # [9] Ex. H, # [10] Ex. I, # [11] Ex. J, # [12] Ex. K, # [13] Ex. L, # [14] Ex. M, # [15] Ex. N)(Tigan, Jeremy) (Entered: 02/19/2025) | |
| 02/19/25 | [SEALED] MEMORANDUM ORDER- re [185] MOTION for Teleconference to Resolve Discovery Dispute, [186] MOTION for Teleconference to Resolve Discovery Dispute. IT IS FURTHER ORDERED that the discovery dispute teleconference set for February 20, 2025 at 2:00 p.m. is CANCELLED. Signed by Judge Sherry R. Fallon on 2/19/2025.This order has been emailed to local counsel for the plaintiffs, Novitium and Zenara. (lih) (Entered: 02/19/2025) | |
| 02/13/25 | [SEALED] Letter to The Honorable Sherry R. Fallon from Anne Shea Gaza re [190] Letter. (Attachments: # [1] Exhibit 1, # [2] Exhibit 2, # [3] Exhibit 3, # [4] Exhibit 4, # [5] Exhibit 5, # [6] Exhibit 6, # [7] Exhibit 7, # [8] Exhibit 8)(Gaza, Anne) Modified on 2/13/2025 (lih). (Entered: 02/13/2025) | |
| 02/13/25 | [SEALED] Letter to The Honorable Sherry R. Fallon from Richard C. Weinblatt re [191] Letter. (Attachments: # [1] Exhibit A, # [2] Exhibit B, # [3] Exhibit C, # [4] Exhibit D, # [5] Exhibit E, # [6] Exhibit F, # [7] Exhibit G, # [8] Exhibit H, # [9] Declaration of Dr. Bhaskar Reddy Pitta)(Weinblatt, Richard) Modified on 2/13/2025 (lih). (Entered: 02/13/2025) | |
| 02/12/25 | [SEALED] Letter to the Honorable Sherry R. Fallon from Jeremy A. Tigan regarding Plaintiffs' Discovery Dispute with Zenara. (Attachments: # [1] Text of Proposed Order, # [2] Exhibit A, # [3] Exhibit B, # [4] Exhibit C, # [5] Exhibit D, # [6] Exhibit E, # [7] Exhibit F, # [8] Exhibit G, # [9] Exhibit H, # [10] Exhibit I)(Tigan, Jeremy) (Entered: 02/12/2025) | |
| 02/12/25 | [SEALED] Letter to the Honorable Sherry R. Fallon from Jeremy A. Tigan regarding Plaintiffs' Discovery Dispute with Novitium. (Attachments: # [1] Text of Proposed Order, # [2] Exhibit A, # [3] Exhibit B, # [4] Exhibit C, # [5] Exhibit D, # [6] Exhibit E, # [7] Exhibit F, # [8] Exhibit G, # [9] Exhibit H, # [10] Exhibit I, # [11] Exhibit J, # [12] Exhibit K, # [13] Exhibit L, # [14] Exhibit M, # [15] Exhibit N)(Tigan, Jeremy) (Entered: 02/12/2025) | |
| 01/31/25 | WAIVER OF SERVICE returned executed by Harmony Biosciences, LLC, Harmony Biosciences Management, Inc., Bioproject Societe Civile de Recherche, Bioprojet Pharma SAS: For Lupin Pharmaceuticals, Inc. waiver sent on 1/27/2025, answer due 3/28/2025. (Tigan, Jeremy) (Entered: 01/31/2025) | |
| 01/31/25 | WAIVER OF SERVICE returned executed by Harmony Biosciences, LLC, Harmony Biosciences Management, Inc., Bioproject Societe Civile de Recherche, Bioprojet Pharma SAS: For Lupin Limited waiver sent on 1/27/2025, answer due 3/28/2025. (Tigan, Jeremy) (Entered: 01/31/2025) | |
| 01/30/25 | NOTICE OF SERVICE of Plaintiffs' Responses and Objections to Defendants' Second Set of Requests for Production (No. 56) filed by Harmony Biosciences, LLC, Bioprojet Societe Civile de Recherche, Bioprojet Pharma SAS.(Tigan, Jeremy) (Entered: 01/30/2025) |